Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 19 OTHER 17 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 49 Prostatic Neoplasms 38 Carcinoma, Non-Small-Cell Lung 28 Neoplasms 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Multiple Myeloma 23 Lymphoma 20 Leukemia, Myeloid, Acute 17 Colorectal Neoplasms 17 Melanoma 14 Lung Neoplasms 13 Hodgkin Disease 11 Brain Neoplasms 11 Medulloblastoma 10 Lymphoma, Non-Hodgkin 10 HIV Infections 10 Glioblastoma 10 Squamous Cell Carcinoma of Head and Neck 9 Pancreatic Neoplasms 9 Neoplasm Metastasis 9 Leukemia, Biphenotypic, Acute 9 Leukemia 9 Head and Neck Neoplasms 9 Neuroblastoma 8 Hematologic Neoplasms 8 Ependymoma 8 Glioma 7 Carcinoma, Renal Cell 7 Astrocytoma 7 Sarcoma, Kaposi 6

Interventions

Trastuzumab 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Advanced Cancer × 1 year × Clear all

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡